Synonyms: EIDD-2801|MK-4482|β-D-N4-Hydroxycytidine-5′-isopropyl ester


CAS
2492423-29-5
Formulation
A crystalline solid
Purity
≥98%
MW
329,30598
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
A prodrug form of EIDD-1931; reduces body weight loss, lung hemorrhage, and lung viral titers, as well as improves pulmonary function in mouse models of SARS-CoV or MERS-CoV infection when administered prophylactically at 2 hours pre-infection or therapeutically at 12 hours post-infection at 500 mg/kg; reduces shed virus load and fever in ferret models of H1N1 or H3N2 influenza A virus infection at 100 mg/kg twice per day
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).